Zobrazeno 1 - 10
of 236
pro vyhledávání: '"J Taljaard"'
Publikováno v:
South African Medical Journal, Vol 114, Iss 2 (2024)
Vaccination is key to eliminating hepatitis B virus infection in South Africa (SA). Despite introducing immunisation in 1995, as part of the expanded programme of immunisation (EPI), hepatitis B virus infection remains endemic, and EPI vaccine covera
Externí odkaz:
https://doaj.org/article/730f9576279247a0b604c8da267dfa2a
Autor:
V Pillay-Fuentes Lorente, R van Rensburg, M S Moolla, M McCaul, A Parker, J Taljaard, H Reuter, E H Decloedt
Publikováno v:
South African Medical Journal, Vol 112, Iss 7 (2022)
Background. An increased incidence of thromboembolic events in hospitalised COVID‐19 patients has been demonstrated despite the use of low‐molecular‐weight heparin (LMWH). Antiplatelet therapy prior to admission and early in the disease course
Externí odkaz:
https://doaj.org/article/607aaebf47724602a631773dbb101926
Publikováno v:
South African Medical Journal, Vol 107, Iss 11, Pp 929-929 (2017)
Externí odkaz:
https://doaj.org/article/6726c4e359064af4a1d2e0cb14bcab5e
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss , Pp 334-337 (2020)
Estimates of health capacities in the context of the coronavirus disease 2019 (COVID-19) pandemic indicate that most low- and middle-income countries (LMICs) are not operationally ready to manage this health emergency. Motivated by worldwide successe
Externí odkaz:
https://doaj.org/article/11fd649220664999a389aaea05034d78
Publikováno v:
South African Journal of Surgery; Vol. 58 No. 1 (2020); 27-32
SOUTH AFRICAN JOURNAL OF SURGERY, 58(1), 27-32. SA MEDICAL ASSOC
South African Journal of Surgery, Volume: 58, Issue: 1, Pages: 27-32, Published: MAR 2020
SOUTH AFRICAN JOURNAL OF SURGERY, 58(1), 27-32. SA MEDICAL ASSOC
South African Journal of Surgery, Volume: 58, Issue: 1, Pages: 27-32, Published: MAR 2020
Background: Limited evidence supports the efficacy of antimicrobial prophylaxis (AP) in prevention of gunshot woundrelated (GSW-related) infection in resource restricted areas. At Tygerberg Hospital, South Africa, it is standard care for GSW patients
Autor:
Roland van Rensburg, Sam Nightingale, Naeem Brey, Christine H Albertyn, Tracy A Kellermann, Jantjie J Taljaard, Tonya M Esterhuizen, Phumla Z Sinxadi, Eric H Decloedt
Publikováno v:
Clinical Infectious Diseases. 75:399-405
Background The late-onset efavirenz neurotoxicity syndrome (LENS) presents as ataxia and/or encephalopathy with supratherapeutic efavirenz plasma concentrations (>4 µg/mL). Efavirenz is primarily metabolized by cytochrome P450 2B6 (CYP2B6), with CYP
Autor:
Colette C Pienaar, Jantjie J Taljaard, Hans Prozesky, Philip Pg Herbst, Jacques Jt Janson, Alfonso Ajk Pecoraro, Anton Af Doubell
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 40:1873-1879
Previous reports have highlighted the high prevalence of blood culture negative endocarditis (BCNE) in South Africa. The Tygerberg Endocarditis Cohort (TEC) study is an ongoing prospective cohort study of patients with confirmed or suspected IE prese
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 112(1)
Incorrect empirical antibiotic therapy is one of the factors that contribute to poor clinical outcomes and the development of antimicrobial resistance. Knowledge of the local infectious disease burden and antibiotic resistance patterns can assist wit
Autor:
Arifa Parker, Linda Boloko, Muhammad S. Moolla, Nabilah Ebrahim, Birhanu T. Ayele, Alistair G. B. Broadhurst, Boitumelo Mashigo, Gideon Titus, Timothy de Wet, Nicholas Boliter, Michael-Jon Rosslee, Nectarios Papavarnavas, Riezaah Abrahams, Marc Mendelson, Sipho Dlamini, Jantjie J. Taljaard, Hans W. Prozesky, Abdurasiet Mowlana, Abraham J. Viljoen, Neshaad Schrueder, Brian W. Allwood, Usha Lalla, Joel A. Dave, Greg Calligaro, Dion Levin, Deborah Maughan, Ntobeko A. B. Ntusi, Peter S. Nyasulu, Graeme Meintjes, Coenraad F. N. Koegelenberg, Ayanda T. Mnguni, Sean Wasserman
Publikováno v:
BMC Infectious Diseases
Background There is still a paucity of evidence on the outcomes of coronavirus disease 2019 (COVID-19) among people living with human immunodeficiency virus (PWH) and those co-infected with tuberculosis (TB), particularly in areas where these conditi
Autor:
U, Lalla, C F N, Koegelenberg, B W, Allwood, L N, Sigwadhi, E M, Irusen, A E, Zemlin, T E, Masha, R T, Erasmus, Z C, Chapanduka, H, Prozesky, J, Taljaard, A, Parker, E H, Decloedt, F, Retief, T P, Jalavu, V D, Ngah, A, Yalew, J L, Tamuzi, N, Baines, M, McAllister, A, Zumla, P S, Nyasulu
Publikováno v:
African journal of thoracic and critical care medicine. 27(4)
The second wave of coronavirus disease 2019 (COVID-19), dominated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant, has been reported to be associated with increased severity in South Africa (SA).To describe and compar